Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Birth spacing and maternal risk of invasive epithelial ovarian cancer in a Swedish nationwide cohort.

Baik I, Lambe M, Liu Q, Chie L, Cnattingius S, Mucci LA, Riman T, Ekbom A, Adami HO, Hsieh CC.

Cancer Causes Control. 2008 Dec;19(10):1131-7. doi: 10.1007/s10552-008-9178-x. Epub 2008 May 29.

2.

Predictors of ovarian cancer survival: a population-based prospective study in Sweden.

Yang L, Klint A, Lambe M, Bellocco R, Riman T, Bergfeldt K, Persson I, Weiderpass E.

Int J Cancer. 2008 Aug 1;123(3):672-9. doi: 10.1002/ijc.23429.

3.

Gender of offspring and maternal risk of invasive epithelial ovarian cancer.

Baik I, Lambe M, Liu Q, Cnattingius S, Mucci LA, Riman T, Ekbom A, Adami HO, Hsieh CC.

Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2314-20.

4.

Gestational age and fetal growth in relation to maternal ovarian cancer risk in a Swedish cohort.

Mucci LA, Dickman PW, Lambe M, Adami HO, Trichopoulos D, Riman T, Hsieh CC, Cnattingius S.

Cancer Epidemiol Biomarkers Prev. 2007 Sep;16(9):1828-32.

5.

Hormone replacement therapy and ovarian cancer risk--any news?

Riman T.

Acta Obstet Gynecol Scand. 2007;86(9):1032-4. No abstract available.

PMID:
17712640
6.

A prospective study of the transient decrease in ovarian cancer risk following childbirth.

Liu Q, Lambe M, Baik I, Cnattingius S, Riman T, Ekbom A, Adami HO, Hsieh CC.

Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2508-13.

7.

Use of hormone replacement therapy before and after ovarian cancer diagnosis and ovarian cancer survival.

Mascarenhas C, Lambe M, Bellocco R, Bergfeldt K, Riman T, Persson I, Weiderpass E.

Int J Cancer. 2006 Dec 15;119(12):2907-15.

8.

Some life-style factors and the risk of invasive epithelial ovarian cancer in Swedish women.

Riman T, Dickman PW, Nilsson S, Nordlinder H, Magnusson CM, Persson IR.

Eur J Epidemiol. 2004;19(11):1011-9.

PMID:
15648594
9.

Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies.

Riman T, Nilsson S, Persson IR.

Acta Obstet Gynecol Scand. 2004 Sep;83(9):783-95. Review.

PMID:
15315588
10.

Hormone replacement therapy and epithelial ovarian cancer: is there and association?

Riman T.

J Br Menopause Soc. 2003 Jun;9(2):61-8. Review.

PMID:
12844427
11.

Risk factors for invasive epithelial ovarian cancer: results from a Swedish case-control study.

Riman T, Dickman PW, Nilsson S, Correia N, Nordlinder H, Magnusson CM, Persson IR.

Am J Epidemiol. 2002 Aug 15;156(4):363-73.

PMID:
12181107
12.

Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in Swedish women.

Riman T, Dickman PW, Nilsson S, Correia N, Nordlinder H, Magnusson CM, Weiderpass E, Persson IR.

J Natl Cancer Inst. 2002 Apr 3;94(7):497-504.

PMID:
11929950
13.

Risk factors for epithelial borderline ovarian tumors: results of a Swedish case-control study.

Riman T, Dickman PW, Nilsson S, Correia N, Nordlinder H, Magnusson CM, Persson IR.

Gynecol Oncol. 2001 Dec;83(3):575-85.

PMID:
11733975
14.

New leads on ovarian carcinogenesis.

Persson I, Riman T.

Epidemiology. 2000 Mar;11(2):97-8. No abstract available.

PMID:
11021601
15.

Hormonal aspects of epithelial ovarian cancer: review of epidemiological evidence.

Riman T, Persson I, Nilsson S.

Clin Endocrinol (Oxf). 1998 Dec;49(6):695-707. Review.

PMID:
10209555

Supplemental Content

Support Center